Related Experiment Video
Updated: Dec 27, 2025
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Screening Genes Promoting Exit from Naive Pluripotency Based on Genome-Scale CRISPR-Cas9 Knockout
Bin Yang1,2, Junqi Kuang3, Chuman Wu3
1The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China.
Abstract:
Two of the main problems of stem cell and regenerative medicine are the exit of pluripotency and differentiation to functional cells or tissues. The answer to these two problems holds great value in the clinical translation of stem cell as well as regenerative medicine research. Although piling researches have revealed the truth about pluripotency maintenance, the mechanisms underlying pluripotent cell self-renewal, proliferation, and differentiation into specific cell lineages or tissues are yet to be defined. To this end, we took full advantage of a novel technology, namely, the genome-scale CRISPR-Cas9 knockout (GeCKO). As an effective way of introducing targeted loss-of-function mutations at specific sites in the genome, GeCKO is able to screen in an unbiased manner for key genes that promote exit from pluripotency in mouse embryonic stem cells (mESCs) for the first time. In this study, we successfully established a model based on GeCKO to screen the key genes in pluripotency withdrawal. Our strategies included lentiviral package and infection technology, lenti-Cas9 gene knockout technology, shRNA gene knockdown technology, next-generation sequencing, model-based analysis of genome-scale CRISPR-Cas9 knockout (MAGeCK analysis), GO analysis, and other methods. Our findings provide a novel approach for large-scale screening of genes involved in pluripotency exit and offer an entry point for cell fate regulation research.
Insights
Researchers used genome-scale CRISPR-Cas9 knockout (GeCKO) to identify key genes driving pluripotent stem cell exit. This novel screening approach advances understanding of cell fate regulation for regenerative medicine applications.
Area of Science:
- Stem Cell Biology
- Regenerative Medicine
- Genomics
Background:
- Clinical translation of stem cell research faces challenges in controlling pluripotency exit and cell differentiation.
- Mechanisms governing pluripotent stem cell self-renewal and differentiation remain incompletely understood.
Purpose of the Study:
- To develop and apply a genome-scale CRISPR-Cas9 knockout (GeCKO) screening model for unbiased identification of genes involved in pluripotency exit in mouse embryonic stem cells (mESCs).
- To provide a novel approach for large-scale gene screening in cell fate regulation research.
Main Methods:
- Utilized genome-scale CRISPR-Cas9 knockout (GeCKO) technology for targeted loss-of-function mutations.
- Employed lentiviral packaging and infection, lenti-Cas9 gene knockout, and shRNA gene knockdown.
- Performed next-generation sequencing and model-based analysis of genome-scale CRISPR-Cas9 knockout (MAGeCK analysis), alongside Gene Ontology (GO) analysis.
Main Results:
- Successfully established a GeCKO-based screening model to identify key genes regulating pluripotency withdrawal in mESCs.
- Demonstrated the efficacy of GeCKO for unbiased, large-scale screening of genes influencing stem cell fate.
Conclusions:
- The developed GeCKO screening model offers a powerful new tool for dissecting the genetic underpinnings of pluripotency exit.
- Findings provide a foundation for further research into cell fate regulation and potential therapeutic strategies in regenerative medicine.
